Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous
system (CNS) from toxins and pathogens in blood. However, the presence of BBB …

The therapies targeting mutations of driver genes in cancer have advanced into clinical trials
for a variety of tumors. In glioblastoma (GBM), epidermal growth factor receptor (EGFR) is …

At the moment, anaplastic changes within the brain are challenging due to the complexity of
neural tissue, leading to the inefficiency of therapeutic protocols. The existence of a cellular …

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases in the
elderly population. Despite significant advances in studies of the pathobiology on AD, there …

Alzheimer's disease, a progressive neurodegenerative condition, is characterized by a
gradual decline in cognitive functions. Current treatment approaches primarily involve the …

Central nervous system (CNS) infections can lead to high mortality and severe morbidity.
Diagnosis, monitoring, and assessing response to therapy of CNS infections is particularly …

ABSTRACT Introduction Viral nanoparticles (VNPs) are virus-based nanocarriers that have
been studied extensively and intensively for biomedical applications. However, their clinical …

Determination of solubility via theoretical approaches was carried out in this study. Because
of its importance to the expansion of the pharmaceutical industry, this study models …

There is increased focus on developing tools to image large biomolecules, such as
antibodies, within the brain using positron emission tomography (PET). The inverse electron …

METHODS: A review of current literature was conducted through a MEDLINE search
inclusive of articles on FUS, BBB, and brain tumor barrier, including human, modeling, and …